Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity.

Yong-Sheng LiZhiyong ShenZhen ChaiYizhi ZhanYaowei ZhangZhengyu LiuYuechen LiuZhenkang LiMingdao LinZhanqiao ZhangWei LiuShenyuan GuanJinchao ZhangJunying QianYi DingGuoxin LiYuan FangHaijun Deng

Published in: Gut (2023)

Targeting MS4A4A could enhance the ICI efficacy and represent a new anticancer immunotherapy.

Keyphrases

mass spectrometry
multiple sclerosis
ms ms
cancer therapy